Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Others have calculated about 300m of the 500m share authorization increase are already spoken for with warrants and "C" shares, so that is already built in to the stock price.
That leaves 200M to issue, if needed, for operations.
Most ASM are quite boring and don't offer much, unless in person and you can glean info from body language, whispers and winks.
I look back at some of the 2018/2019 ASM's and they made still talked about statements. I expect more long-lasting statements AGAIN AS THEY ALWAYS DO.
AF serves a niche market of journalism.
Nah, I'll be drinking Champagne, as 12/31 is New Year's Eve... and the ASM was the day before 12/30.
You know what the answer to Bullshit is? Shutting the hell up.
That is exactly why the company has shut up. All the attacks from every direction. From uncoverable shorts or BP losing fat revenue streams or attempted takeovers from Woodie.
Have a Great News Year.
Agree. Also, since the warrants/options/C's are already baked into the stock price, it's estimated to only be about 200M increase of potentially offerable shares, if the company chooses/needs to.
What's the chance NICE did clean-up an old appraisal project, ID 836, to make room for a murcidencel project appraisal instead? Meaning not specific to GBM? Would NICE be able to do that, or do they have to create a new project for each indication?
He's some PR's for you. https://nwbio.com/press-releases/
Low volume should scare the crap out of shorts. So many shares being held with a Diamond Grip. There will be literally no shares to cover with until $15+ pps.
Voted "FOR" all. We have to put the 2020 basic and all to common 'enrichment suit' to a close. This will help keep a clean house...company might be coming over.
Totally reasonable statement to make.
If shareholders re-vote that they approved the 2020 options and awards, the 'enrichment' lawsuit should really be dismissed.
Citadel is under pressure, hence, the company's move to the Desantis Peninsula and Florida's generous asset protection. Buy a $200,000,000 homestead and no one can ever take it, no matter who sues you.
Timing is everything. LP is a pro, 12/30/22... LOL... I love it....
I think since the ticker was 'deleted', anything naked never existed...financial fudruckery. You cannot cover what no longer exists. IMHO, and this situation is messed up.
I'll try... so, you 'borrow' $1,000 from a friend. Somehow, he is brutally murdered, like, his head is almost detached from the knife wound... now, you don't have to pay him back.
It's like money in the bank. Totally legal, except the murder and fraud part....
FINRA Update-ish
$NWBO Finra updated 12/7, 12/8 so far.#finrafruad #CitadelScandal pic.twitter.com/P6gg04ZFBc
— LearningEveryTrade 🚀📈💰 (@EveryTrade) December 12, 2022
it's also a pattern for Painting the Tape. And, I have noticed this pattern, for years actually. Thanks though.
Referred to: Magistrate Judge Gabriel W. Gorenstein
I am not an attorney, but found this at Pacer website on 12/6/22 So, looks like Judge Gorenstein to me.
https://www.pacermonitor.com/public/case/47001949/Northwest_Biotherpeutics,_Inc_v_Canaccord_Genuity_LLC_et_al
"news" was a Jedi Mind Trick to get some to place market orders at open, promptly followed by someone shorting/selling. Only 'news' is Flaskworks posted a new job opening. That makes 'cover' for saying 'news in AM'. IMHO.
Flaskworks Hiring Product Development Engineer. https://www.linkedin.com/jobs/view/3396791490/?refId=JlQCaTNPAvx3o%2FRiU7jrGA%3D%3D&trackingId=MrBKxFmuz7BTMOQPHwF92A%3D%3D
image of psPD from immune system response.
The issue has been that independent radiologists said there was progression, when, in fact, it was the immune response making the tumor look like it was growing on the crude early 2010's imaging technology. Dr. Liau has said half the time they were wrong. Everyone was blinded as to DCVAX or Placebo/SOC until point of crossover. I have not heard comment from the company on what they did "at" crossover to see if they had in fact been live dcvax or placebo.
hence Citadel moving to Florida... trying to cozy up to someone who might become President.
The gun point robbery of an employee of Citadel is nothing compare to the crimes of murdering patients by killing biotechs that could have helped someone.
That storyline for moving HQ to The Desantis Peninsula is a scapegoat.
JED plus, for Fintel non-subscribers, both the short shares available and the short borrow fee are 'fully viewable'. It used to be only the top item you could see.
$NWBO #CitadelScandal $GME $AMC #MOASS
— LearningEveryTrade 🚀📈💰 (@EveryTrade) December 3, 2022
So, I don't pay Fintel. These two categories have always been hidden, except the top line. Very ODD given the Market Maker Lawsuit. https://t.co/KXlLjceX5ghttps://t.co/6audMotlj2https://t.co/JJbnFpOuxd pic.twitter.com/WHNDyV0o7W
Action =
1. Cofer Black
2. Lock Data
3. NYAS
4. JAMA
5. Plenary SNO
6. Sue Market Makers
7. Commence delayed ASM due to previous REAL ACTIONs !!
8. Discovery- It's not just a TV channel anymore.
Looks like a YES vote is in order!!
Dr. Stupp DCVAX article. 12-8-22 http://prac.co/l/2pkmmnj3
Could be from more DNS attacks at his site, too many visits, OR, and more likely, at the request of NWBO.
Easy to Google it.
I suppose the reason is sealioning? Makes sense to me.
premarket vol 1,000, now 6,000.
They say 1,000 is the 'code' for 'don't let it run'.. looks true today. LOL.
an SEC Registered Investment Adviser needs to be more careful.
This is beyond a 'random social media poster' saying this.
Go look for yourself. Easy to do. Search reddit for $nwbo.
Plus, it's impossible for someone to know if a buyer of NWBO owns APE or AMC or GME.
Hygro, Why the flip-flop?
25 years ago job resume dredging. Embarrasing.
The Enron scandal was an accounting scandal involving Enron Corporation
Until 1997, Linda Powers was Senior VP, Global Finance, Enron International (operating subsidiary) NOT to be confused or comingled with the "Corporation."
Enron International (EI) was Enron's wholesale asset development and asset management business. Its primary emphasis was developing and building natural gas power plants outside North America. Enron Engineering and Construction Company (EECC) was a wholly owned subsidiary of Enron International, and built almost all of Enron International's power plants. Unlike other business units of Enron, Enron International had a strong cash flow on bankruptcy filing.[citation needed] Enron International consisted of all of Enron's foreign power projects, including ones in Europe.
So, having a strong cash flow, well, she was doing a great job running that foreign Power Plant Building company.
Chicken or the Egg ?? Management used to talk, but rotated to silence due to relentless and continual attacks on them. Hmmmm.
If the MM Manipulation had not occured/occurring, the dilution would be much less off-putting.
So, knowing NWBO, shareholders and patients are crime victims should give some understanding and consolation.
I feel so good the company is on it. Should quiet some naysayers.
heck, maybe some analysts will feel more comfortable to actually look at it the the JAMAOnc article, with the long supplements.
norisk... I have been not drinking the MRK/NWBO patent protection Kool-aid because of this 2021 article, now further backed up by your current find. Even if they loose partections for I.V., their shot version of Keytruda will be the more patient friendly and cheaper option. They will get the I.P./Patent protection they need after 2028. IMHO.
https://www.fiercepharma.com/drug-delivery/merck-posts-early-clinical-data-subcutaneous-keytruda-setting-stage-for-further
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-could-keep-its-patent-edge-by-shifting-keytruda-cancer-drug-simple-shot-2022-12-02/
OncoWolf. Not a Jock.
iBorrow 17.3 % 700,000 2022-12-02 09:15:03
Getting expensive... LOL...
I like the jury trial demand.
https://www.wsj.com/articles/biotech-company-says-citadel-other-big-traders-manipulated-its-stock-price-11669901683
$NWBO and $AVXL might have the same issue. I know many posters here also post nwbo and might be distracted this morning on avxl. ICYWI.